The accuracy of the diagnosis is of paramount importance for the implementation of the treatment. Of course the lymph node biopsy, that is to say the sampling and laboratory examination of the ganglion, will be performed. Several other tests will be needed to assess the severity of the disease. While the blood test allows a thorough examination of the different cell lines, radiological exploration (radio, CT scan, ultrasound ...) can identify the lymph nodes affected. A sample taken from a bone (bone marrow), then a laboratory analysis, are also performed.
Depending on the outcome of these examinations, a tumor extension assessment will be performed, to establish the best possible therapeutic strategy.
The treatments for Hodgkin's disease are effective, and the cure rate is high. As a result, the prognosis for Hodgkin's disease is relatively good with an overall survival of 91% at 5 years of age for children and adults under 20 years of age. This is the result of an evolution of the therapeutic strategy towards a preponderant and tailor-made chemotherapy, associated with radiotherapy reserved for large ganglionic masses. The therapeutic strategy depends on the stages of evolution of Hodgkin's disease.
This treatment is done in a hematology department.
Progress has been made to improve survival in the few forms that remain severe and to reduce the burden of treatment.